Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

18.97
Delayed Data
As of Apr 28
 +0.04 / +0.21%
Today’s Change
11.41
Today|||52-Week Range
24.88
+54.60%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close18.93
Today’s open19.00
Day’s range18.74 - 19.28
Volume1,783,141
Average volume (3 months)1,798,139
Market cap$2.9B
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)-14.94%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book32.98

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...+0.07+0.28%
EXASExact Sciences Corp-0.13-0.43%
XONIntrexon Corp-0.63-2.93%
AVXSAveXis Inc+1.74+2.21%
Data as of 4:02pm ET, 04/28/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts